GH Guardant Health, Inc.

NASDAQ
$157.21

Guardant Health, Inc. (GH) is expected to report earnings on October 29, 2026, after the market close. The consensus earnings estimate is a loss of $0.65 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -3.3% since its last earnings release on July 30, 2026.

Guardant Health Beat Expectations, Raises Guidance
Thursday, July 30, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Oct 29
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.65) (GAAP)
Rev est $339.31M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $161.82

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Guardant Health, Inc.

Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary tests, vast data sets and advanced analytics.

Sector

Healthcare

Industry

Medical Labs & Research